# Cosopt Versus Xalatan

> **NCT00273429** · PHASE4 · COMPLETED · sponsor: **Pharmaceutical Research Network**

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** timolol maleate 0.5%
- **DRUG:** dorzolamide/timolol maleate fixed combination
- **DRUG:** latanoprost 0.005%
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00273429
- **Lead sponsor:** Pharmaceutical Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** — (—)
- **Last updated:** 2007-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00273429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00273429, "Cosopt Versus Xalatan". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00273429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*